Feb 26, 2023 03:00PM

Feb 9, 2023 11:05AM

Feb 3, 2023 09:00AM

Jan 23, 2023 08:01AM

Jan 23, 2023 08:00AM

Feb 18, 2021 07:20AM

Feb 17, 2021 07:00AM Blueprint Medicines Reports Fourth Quarter and Full Year 2020 Financial Results

Oct 29, 2020 07:00AM

Sep 8, 2020 08:04AM

Sep 4, 2020 07:00PM

Jul 30, 2020 07:00AM

Jul 14, 2020 05:51AM

Jul 14, 2020 01:00AM

May 29, 2020 08:14AM Blueprint Medicines (BPMC) Presents Data from Ongoing ARROW Clinical Trial of Pralsetinib in Patients w/ RET Fusion-Positive NSCLC, Thyroid Cancer & Other Solid Tumors

May 29, 2020 08:00AM

Apr 1, 2020 08:00AM

Feb 13, 2020 07:00AM

Feb 6, 2020 08:18AM

Feb 6, 2020 08:00AM

Jan 9, 2020 03:53PM

Jan 9, 2020 03:52PM Blueprint Medicines Announces FDA Approval of AYVAKIT™ (avapritinib) for the Treatment of Adults with Unresectable or Metastatic PDGFRA Exon 18 Mutant Gastrointestinal Stromal Tumor

Nov 5, 2019 07:00AM

Aug 7, 2019 08:11AM

Aug 7, 2019 08:00AM

14,982 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All